IL6 and neoplasm: Importantly, these findings align with scRNA-seq data revealing enrichment of cytokine-cytokine receptor pathways in tumor-infiltrating NK cells, suggesting IL-6 as a key modulator of NK cell dysfunction in the tumor microenvironment.